Underdown Brian J.
Insider CIK 1526335 · ARGS Director, 10% owner · VSTA Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VTGN VistaGen Therapeutics, Inc | M Exercise deriv | 2021-03-19 | 2021-03-22 | 2,500 | — | $0 | 0 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | M Exercise | 2021-03-19 | 2021-03-22 | 2,500 | $1.50 | $3.8K | 2,500 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2020-12-30 | 2021-01-04 | 75,000 | — | $0 | 75,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2020-04-23 | 2020-04-27 | 75,000 | — | $0 | 75,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2019-10-21 | 2019-10-22 | 75,000 | — | $0 | 75,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2019-05-23 | 2019-05-28 | 50,000 | — | $0 | 50,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | D To issuer deriv | 2018-08-29 | 2018-08-31 | 35,000 | — | $0 | 0 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2018-08-29 | 2018-08-31 | 6,250 | — | $0 | 6,250 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | D To issuer deriv | 2018-08-29 | 2018-08-31 | 6,250 | — | $0 | 0 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2018-08-29 | 2018-08-31 | 500 | — | $0 | 500 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | D To issuer deriv | 2018-08-29 | 2018-08-31 | 500 | — | $0 | 0 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2018-08-29 | 2018-08-31 | 35,000 | — | $0 | 35,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | D To issuer deriv | 2018-08-29 | 2018-08-31 | 2,500 | — | $0 | 0 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2018-08-29 | 2018-08-31 | 25,000 | — | $0 | 25,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | D To issuer deriv | 2018-08-29 | 2018-08-31 | 25,000 | — | $0 | 0 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2018-08-29 | 2018-08-31 | 25,000 | — | $0 | 25,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | D To issuer deriv | 2018-08-29 | 2018-08-31 | 25,000 | — | $0 | 0 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2018-08-29 | 2018-08-31 | 2,500 | — | $0 | 2,500 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2018-08-05 | 2018-08-06 | 75,000 | — | $0 | 75,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2018-02-02 | 2018-02-05 | 100,000 | — | $0 | 100,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2017-09-19 | 2017-09-20 | 50,000 | — | $0 | 50,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2017-04-26 | 2017-04-28 | 35,000 | — | $0 | 35,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2016-11-09 | 2016-11-10 | 25,000 | — | $0 | 25,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2016-06-19 | 2016-06-21 | 25,000 | — | $0 | 25,000 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2015-11-11 | 2015-11-13 | 50,000 | — | $0 | 50,000 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | D To issuer deriv | 2015-11-11 | 2015-11-13 | 50,000 | — | $0 | 0 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2015-11-11 | 2015-11-13 | 20,000 | — | $0 | 20,000 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | D To issuer deriv | 2015-11-11 | 2015-11-13 | 20,000 | — | $0 | 0 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2015-11-11 | 2015-11-13 | 2,500 | — | $0 | 2,500 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | D To issuer deriv | 2015-11-11 | 2015-11-13 | 2,500 | — | $0 | 0 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | D To issuer deriv | 2015-11-11 | 2015-11-13 | 2,500 | — | $0 | 0 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2015-11-11 | 2015-11-13 | 7,500 | — | $0 | 7,500 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | D To issuer deriv | 2015-11-11 | 2015-11-13 | 7,500 | — | $0 | 0 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2015-11-11 | 2015-11-13 | 2,500 | — | $0 | 2,500 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2015-09-02 | 2015-09-04 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ARGS ARGOS THERAPEUTICS INC | A Award deriv | 2015-06-17 | 2015-06-18 | 5,500 | — | $0 | 16,500 | SEC↗ |
| ARGS ARGOS THERAPEUTICS INC | A Award deriv | 2015-06-17 | 2015-06-19 | 5,500 | — | $0 | 5,500 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2015-01-11 | 2015-01-13 | 20,000 | — | $0 | 20,000 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | J Other deriv | 2014-03-19 | 2014-03-21 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ARGS ARGOS THERAPEUTICS INC | C Conversion deriv | 2014-02-12 | 2014-02-12 | 569,990 | — | $0 | 0 | SEC↗ |
| ARGS ARGOS THERAPEUTICS INC | C Conversion deriv | 2014-02-12 | 2014-02-12 | 582,769 | — | $0 | 0 | SEC↗ |
| ARGS ARGOS THERAPEUTICS INC | C Conversion deriv | 2014-02-12 | 2014-02-12 | 43,185 | — | $0 | 0 | SEC↗ |
| ARGS ARGOS THERAPEUTICS INC | C Conversion deriv | 2014-02-12 | 2014-02-12 | 13,131 | — | $0 | 0 | SEC↗ |
| ARGS ARGOS THERAPEUTICS INC | C Conversion | 2014-02-12 | 2014-02-12 | 582,769 | — | $0 | 639,085 | SEC↗ |
| ARGS ARGOS THERAPEUTICS INC | C Conversion | 2014-02-12 | 2014-02-12 | 569,990 | — | $0 | 1,209,075 | SEC↗ |
| ARGS ARGOS THERAPEUTICS INC | P Buy | 2014-02-12 | 2014-02-12 | 40,497 | $8.00 | $324.0K | 1,249,572 | SEC↗ |
| ARGS ARGOS THERAPEUTICS INC | C Conversion | 2014-02-12 | 2014-02-12 | 43,185 | — | $0 | 56,316 | SEC↗ |
| ARGS ARGOS THERAPEUTICS INC | C Conversion | 2014-02-12 | 2014-02-12 | 13,131 | — | $0 | 13,131 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | D To issuer deriv | 2013-12-20 | 2013-12-24 | 10,000 | — | $0 | 0 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2013-12-20 | 2013-12-24 | 10,000 | — | $0 | 10,000 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | D To issuer deriv | 2013-12-20 | 2013-12-24 | 125,000 | — | $0 | 0 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2013-12-20 | 2013-12-24 | 125,000 | — | $0 | 125,000 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2013-12-20 | 2013-12-24 | 50,000 | — | $0 | 50,000 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | D To issuer deriv | 2013-12-20 | 2013-12-24 | 50,000 | — | $0 | 0 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2013-12-20 | 2013-12-24 | 50,000 | — | $0 | 50,000 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | D To issuer deriv | 2013-12-20 | 2013-12-24 | 50,000 | — | $0 | 0 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | J Other deriv | 2013-03-03 | 2013-03-05 | 150,000 | — | $0 | 150,000 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2012-02-13 | 2012-02-15 | 50,000 | — | $0 | 50,000 | SEC↗ |